SPL 1.08% 9.4¢ starpharma holdings limited

Well if the testing model was good enough for the vaccines and...

  1. 15,618 Posts.
    lightbulb Created with Sketch. 5701
    Well if the testing model was good enough for the vaccines and is endorsed by the World Health Organisation then it should surely further support TGA approval ?


    The model used in this study of VIRALEZE™ is one of the few animal models endorsed by the World Health Organisation (WHO) to accelerate the testing of vaccines and therapeutic agents for COVID-19. 3 The transgenic mouse model expresses the human angiotensin converting enzyme (hACE2) receptor used by SARS-CoV-2 to infect cells in the human nasal cavity and respiratory tract.


    I also liked this comment:

    Collectively, these data illustrate, in this in vivo animal model, the ability of nasally administered VIRALEZE™ to inactivate virus and reduce viral load in the nose, trachea, lung and blood, and the resulting protective benefits of this action on the inflammatory cytokine response.

    GLTAH
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
0.001(1.08%)
Mkt cap ! $39.23M
Open High Low Value Volume
9.4¢ 9.5¢ 9.3¢ $29.92K 320.8K

Buyers (Bids)

No. Vol. Price($)
1 149283 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.6¢ 100000 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.